Altimmune Inc (NASDAQ:ALT)

12.40
Delayed Data
As of Sep 23
 -0.95 / -7.12%
Today’s Change
3.83
Today|||52-Week Range
23.49
+35.37%
Year-to-Date

Today’s Trading

Previous close13.35
Today’s open12.81
Day’s range11.71 - 12.82
Volume152,195
Average volume (3 months)2,324,775
Market cap$706.5M
Data as of 4:00pm ET, 09/23/2022

Growth & Valuation

Earnings growth (last year)-22.94%
Earnings growth (this year)+16.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-46.12%
P/E ratioNM
Price/Sales85.74
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
NSTGNanoString Technolog...-0.12-0.91%
MORMorphoSys AG-0.20-4.28%
AGENAgenus Inc-0.10-4.46%
MRSNMersana Therapeutics...-0.47-7.16%
Data as of 4:00pm ET, 09/23/2022

Financials

Next reporting dateNovember 15, 2022
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$4.4M
Annual profit (last year)-$97.1M
Net profit margin-2,201.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts